C, V., JD, E., M, M., N, P., M, A., G, A., . . . G, C. (2026). Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: A cohort study. ESMO open, 11(2), 106079. https://doi.org/10.1016/j.esmoop.2026.106079
Chicago Style (17th ed.) CitationC, Valenza, et al. "Inadequate Ovarian Function Suppression and Endocrine Therapy Manipulations in Premenopausal Patients with Early Breast Cancer on Adjuvant LHRH Agonist and Aromatase Inhibitor: A Cohort Study." ESMO Open 11, no. 2 (2026): 106079. https://doi.org/10.1016/j.esmoop.2026.106079.
MLA (9th ed.) CitationC, Valenza, et al. "Inadequate Ovarian Function Suppression and Endocrine Therapy Manipulations in Premenopausal Patients with Early Breast Cancer on Adjuvant LHRH Agonist and Aromatase Inhibitor: A Cohort Study." ESMO Open, vol. 11, no. 2, 2026, p. 106079, https://doi.org/10.1016/j.esmoop.2026.106079.